Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
NCT05936242 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-09-19
Summary
The goal of this observational study is to explore inter- and intra-individual determinants of postprandial glucose response in patients with type 1 diabetes using continous glucose monitoring (CGM).
Blood samples and anthropometrics will be collected during hospital visit. Participants will be asked to:
* record a seven-day food diary
* complete EPIC food frequency questionnaire
* complete questionnaires on sleep hygiene
* collect a stool sample
Conditions
Sponsors & Collaborators
-
Federico II University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-18
- Primary Completion
- 2027-07-31
- Completion
- 2028-01-31
Countries
- Italy
Study Locations
More Related Trials
-
Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes
NCT06057246 ·Status: RECRUITING ·Phase: NA
-
Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders
NCT07021456 ·Status: RECRUITING
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
NCT06120556 ·Status: COMPLETED
-
Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention
NCT00934336 ·Status: COMPLETED ·Phase: NA
-
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
NCT05305794 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy
NCT07151924 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
NCT05713448 ·Status: RECRUITING
-
The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
NCT00639613 ·Status: COMPLETED
-
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
NCT00732602 ·Status: COMPLETED ·Phase: NA
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
NCT00562133 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance
NCT02475421 ·Status: COMPLETED ·Phase: NA
-
Sleep Apnea in Type 1 Diabetes
NCT01935765 ·Status: COMPLETED ·Phase: NA
-
Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)
NCT01342939 ·Status: COMPLETED
-
Incretin Action in Physiology and Diabetes
NCT02550548 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Effect of GIP After a Meal in Patients With Type 2 Diabetes
NCT03702660 ·Status: COMPLETED ·Phase: NA
-
AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
NCT05461144 ·Status: NOT_YET_RECRUITING
-
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
NCT05414409 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
NCT03734718 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus
NCT00603031 ·Status: COMPLETED ·Phase: NA
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED